Habib El-Khoury

Internal Medicine

5841 S Maryland Ave
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins.

Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: December 11, 2025

SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors.

SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors.

Journal: Nature cancer

Published: September 07, 2024

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.

Journal: Nature communications

Published: August 12, 2024

Serum free light chains in a racially diverse population including African Americans and populations from South Africa.

Serum free light chains in a racially diverse population including African Americans and populations from South Africa.

Journal: Blood

Published: July 09, 2024

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.

Journal: medRxiv : the preprint server for health sciences

Published: May 03, 2024

Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.

Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.

Journal: Cancer research communications

Published: August 09, 2023

Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population.

Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population.

Journal: Blood advances

Published: May 30, 2023

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.

Journal: The Lancet. Haematology

Published: September 07, 2022

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.

Journal: Cancer cell

Published: February 03, 2022

Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis.

Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis.

Journal: Nature communications

Published: January 10, 2022

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.

Journal: The Lancet. Haematology

Published: December 03, 2021

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia.

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia.

Journal: Blood advances

Published: April 05, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026